The Essential Resource for the Medical Design Engineering Community
CTC microfluidic chip test to solve cancer treatment issues
October 3, 2012 6:30 pm | by I-Micronews | News | CommentsThere are two common dilemmas in the treatment of cancer today: the first is that many therapies, including chemotherapies and radiation can debilitate healthy cells, to the point of killing the person before defeating the cancer. The second problem is that many cancer cells, responding to a prevention drug, can quickly mutate to become immune and more resilient.
NuVasive Announces Conference Call to Discuss Preliminary Unaudited Third Quarter 2012 Revenue Results
October 3, 2012 4:06 pm | by The Associated Press | News | CommentsNuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today preliminary unaudited information regarding expected revenue results for the third quarter 2012. NuVasive anticipates revenue for...
CollabRx Partners with Life Technologies in Molecular Diagnostics
October 3, 2012 4:03 pm | by The Associated Press | News | CommentsSAN FRANCISCO--(BUSINESS WIRE)--Oct 3, 2012--CollabRx, Inc. (NASDAQ: CLRX) today announced a multi-year partnership agreement with Life Technologies Corporation for development and commercialization of CollabRx technology and content resources to be used in conjunction with Life...
Industry-First Hybrid EMR Cart
October 3, 2012 3:44 pm | Product Releases | CommentsShipping for the first time since Peerless Industries announced its expansion into the healthcare market at HIMSS earlier this year, the new PeerCare™ healthcare line delivers a broad portfolio of next-generation...
Nextreme Enables New Generation of Compact PCR Thermal Cyclers for Real-Time DNA Amplification and Analysis
October 3, 2012 3:38 pm | Nextreme Thermal Solutions | Product Releases | CommentsNextreme Thermal Solutions, the leader in micro-scale thermal management and power generation solutions, today announced a new reference design for a compact PCR thermal cycler for field-level DNA amplification.
Three New Accessories for Oxygen Test System
October 3, 2012 2:59 pm | Mocon, Inc. | Product Releases | CommentsMOCON, Inc., the world’s leading manufacturer of package integrity instrumentation, is announcing three new accessories for its breakthrough OpTech® oxygen test system for food and pharmaceutical applications.
St. Jude touts clinical findings for migraine-treating neurostim implant
October 3, 2012 2:43 pm | by Mass Device | News | CommentsSt. Jude Medical touts clinical findings in support of its Genesis peripheral nerve stimulation implant in helping patients with chronic migraines. Medical device giant St. Jude Medical (NYSE:STJ) announced new clinical results for its migraine-management implants, reporting significant relief for patients who, on average, spend more days with migraines than without. News Well, Clinical Trials, Neuromodulation / Neurostimulationread more
Drugs That Can Switch Genes Back 'On' May Represent Future of Cancer Treatment
October 3, 2012 2:27 pm | by Kalorama Information | News | CommentsMethylation treatments that can re-activate stagnant “controller” genes might be a common cancer treatment in the near future, according to Kalorama Information. In a new report, the healthcare market research publisher said that of the rapidly-developing epigenetic approaches – treatments based on new theories outside of what was previously the mainstream thinking of genomics...
Cardiovascular Systems to Release Late-Breaking Peripheral Data at VIVA Conference and Introduce New CSIQ Medical Education Programs
October 3, 2012 2:27 pm | by The Associated Press | News | CommentsST. PAUL, Minn.--(BUSINESS WIRE)--Oct 3, 2012--Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), will present data from its CONFIRM study series at the 10 th annual VIVA conference in Las Vegas, Oct. 9–11, 2012. The CONFIRM study series evaluated the safety and procedural effectiveness of CSI’s...
Study Finds 78% Drop in Surgical Site Infection with Aquacel Ag Surgical Cover Dressing
October 3, 2012 2:18 pm | by ConvaTec | News | CommentsA new study looking at infections following joint replacement surgery finds a 78 percent decrease in joint infections when AQUACEL® Ag SURGICAL cover dressing was used. The results were presented at a ConvaTec-sponsored webcast on the global impact of deadly wound infections and the need to reduce the risk to patients last week in Washington, DC.
Biologics Making Steady Inroads Into Device Landscape, says MedCap Advisors CEO Christopher Velis
October 3, 2012 2:02 pm | by MedCap Advisors | News | CommentsMedCap Advisors, the mergers & acquisition and strategic consulting firm specializing in medical technology, today issued a discussion paper focused on the market penetration of biologics. The paper, “Biologics Revolution: Breaking down barriers to entry for advanced biologic solutions,” captures MedCap CEO Christopher Velis’ insights from the field.
French Decree Hits Device Makers: Crimson Life Sciences Helps Manufacturers Avoid Cash Penalties
October 3, 2012 1:52 pm | by The Associated Press | News | CommentsBOSTON & SAN FRANCISCO--(BUSINESS WIRE)--Oct 3, 2012--Crimson Life Sciences, a division of TransPerfect and the only ISO 13485 and ISO 14971 certified translation provider, has announced new services to help manufacturers cope with French Decree No 2012-743 of May 9, 2012 (full text here )....
Biomet M2A Magnum hip implant lawsuits consolidated in Indiana
October 3, 2012 11:38 am | by Mass Device | News | CommentsA spate of lawsuits filed over Biomet's M2A Magnum metal-on-metal hip implant are consolidated in the U.S. District Court for Northern Indiana. A raft of personal injury lawsuits filed over Biomet's M2A Magnum metal-on-metal hip implant have been consolidated in a federal court in Indiana. The U.S. Judicial Panel on Multidistrict Litigation moved 65 pending cases from other jurisdictions to the U.S. District Court for Northern Indiana, over Biomet's objections. Legal News, News Well, Hips , Implants, Metal-on-Metalread more
ConforMIS Launches Next Generation of Only Patient-Specific Total Knee Replacement Implant System Available on Market
October 3, 2012 11:33 am | News | CommentsConforMIS, Inc. today announced the commercial availability of its iTotal® G2 Knee Replacement System, the only patient-specific total knee replacement (TKR) available on the market today. The iTotal G2 is the next generation version of the iTotal which was FDA cleared in January 2011 and launched into limited surgeon release in May 2011.
Medtronic closes 1st phase of Symplicity renal denervation feasibility trial
October 3, 2012 11:32 am | by Mass Device | News | CommentsMedtronic said the 1st phase of a small trial of the next iteration of its Symplicity device for treating high blood pressure showed a 100% success rate. Medtronic (NYSE:MDT) said it's closed the 1st phase of a feasibility trial for its next-generation Symplicity renal denervation device for high blood pressure. The 9-patient trial delivered a 100% acute success rate in accessing the renal arteries and delivering the therapy, according to a press release. News Well, Clinical Trials, Hypertensionread more
